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Original StudieS
Background: to analyze risk factors associated with gastro-duodenal 
ulcers and erosions in children.
Methods: Open, prospective, multicenter, case-control study carried out 
in 11 european countries in patients with gastric or duodenal ulcers/ero-
sions and 2 age-matched controls each. Possible risk factors were recorded. 
logistic regression models were performed with adjustment for centers and 
age groups.
Results: Seven-hundred thirty-two patients (244 cases, 153 with ero-
sions only and 91 with ulcers, and 488 controls) were recruited. Children 
receiving antimicrobials or acid suppressive drugs before endoscopy were 
excluded (202 cases/390 controls remained for risk factor analysis). Helico-
bacter pylori was detected more frequently in cases than controls but only in 
32.0% versus 20.1% in controls (P = 0.001). independent exposure factors 
for gastric ulcers were male gender (P = 0.001), chronic neurologic disease 
(P = 0.015), chronic renal disease (P < 0.001) and nonsteroidal anti-inflam-
matory drug consumption (P = 0.035). exposure factors for duodenal ulcers 
were H. pylori infection (P < 0.001) and steroid consumption (P = 0.031). 
Chronic renal disease was the only independent factor associated with gas-
tric erosions (P = 0.026), those associated with duodenal erosions being 
H. pylori infection (P = 0.023), active smoking (P = 0.006) and chronic 
arthritis (P = 0.008). no risk factor was identified in 97/202 (48.0%) cases.
Conclusions: H. pylori remains a risk factor for duodenal, but not for gas-
tric lesions in children in countries with low prevalence of infection. no 
risk factor could be identified in half of the children with gastro-duodenal 
ulcers/erosions.
Key Words: Helicobacter pylori, peptic ulcer disease, gastric and duodenal 
ulcer, gastric and duodenal erosions, children
(Pediatr Infect Dis J 2013;32:1324–1329)
Helicobacter pylori is known as an important human pathogen that can cause gastritis and peptic ulcers in adults as well as in 
children, although the general opinion is that ulcers are rare dur-
ing childhood and that H. pylori related gastro-duodenal lesions 
occur only decades after acquisition of the infection.1–4 However, 
in a large european study concerning antimicrobial susceptibil-
ity of H. pylori strains infecting children, gastro-duodenal ulcers 
were found in 3.5% of infected dyspeptic children <6 years of 
age, in 4.6% between the age of 6 and 11 years and in 10.4% of 
those >11 years.5 in another multicenter study evaluating the effi-
cacy of eradication treatments, 64/454 (12.3%) children presented 
gastro-duodenal ulcers and/or erosions.6 Peptic ulcers also occur in 
H. pylori-negative patients, especially those receiving nonsteroidal 
anti-inflammatory drugs (nSaids), as shown in other studies.7–20
in a previous uncontrolled study,1 we assessed the frequency 
of gastro-duodenal ulcers/erosions in dyspeptic children referred 
for upper gastrointestinal (gi) endoscopy in 14 european countries. 
ulcers and/or erosions were observed in 56 of 694 children (8.1%). 
age was identified as an important risk factor, children with ulcers/
erosions being significantly older than those without lesions. Sur-
prisingly, H. pylori infection was present only in 15/56 children 
(27%) and gastrotoxic medications in 13/56 (23%). no risk factor 
was observed in 24/56 children (43%). the relevance of the study 
was, however, limited by its short-time duration (1 month) and the 
absence of a control group.
the aim of the present study is to analyze, in a case-control 
design over a longer period, the risk factors associated with gastric 
and duodenal ulcers or erosions among pediatric patients referred 
for upper gi endoscopy in the same european countries. Since age 
is a major risk factor of gastro-duodenal lesions, to have compa-
rable age distribution, cases and controls were matched for age, 
center and period.
PATIENTS AND METHODS
this open, prospective, multicenter, case-control study was 
carried out during 23 months (January 15, 2008 and december 15, 
2009) in 12 centers from 11 european countries. in each center, 
all the children <18 years undergoing an upper gi endoscopy for 
any indication were enrolled. data were anonymously reported for 
patients presenting gastric or duodenal ulcerations and/or erosions 
and for 2 controls with no ulcer or erosion that immediately fol-
lowed the index case in the same center, cross-matched for age 
groups (1–11 months, 1–5 years, 6–11 years and 12–17 years). the 
following items were recorded: presence of gastric or duodenal 





Patrick Bontems, MD,* Nicolas Kalach, MD, PhD,† Jean Vanderpas, MD, PhD,‡ Barbara Iwanczak, MD,§ 
Thomas Casswall, MD, PhD,¶ Sibylle Koletzko, MD, PhD,‖ Giuseppina Oderda, MD, PhD,**  
Maria José Martinez-Gomez, MD,†† Pedro Urruzuno, MD,‡‡ Angelika Kindermann, MD,§§  
Josef Sykora, MD,¶¶ Gabor Veres, MD, PhD,‖‖ Eleftheria Roma-Giannikou, MD, PhD,***  
Ender Pehlivanoglu, MD, PhD,††† Francis Megraud, MD, PhD,‡‡‡ and Samy Cadranel, MD*
accepted for publication June 17, 2013. 
From the *Paediatric gastroenterology-Hepatology, Queen Fabiola Children’s 
university Hospital, université libre de Bruxelles, Brussels, Belgium; 
†Saint Vincent de Paul Hospital, Clinic of Paediatrics St antoine, groupe-
ment des Hôpitaux de l’institut Catholique de lille (gH-iCl), lille, France; 
‡Medical Microbiology laboratory, Communicable and infectious dis-
eases, Scientific institute of Public Health, Brussels, Belgium; §department 
of Paediatrics, Medical university of Wroclaw, Wroclaw, Poland; ¶depart-
ment of Paediatrics, Karolinska university Hospital, Stockholm, Sweden; 
‖dr v. Hauner Children’s Hospital, university Medical Center, Munich, 
germany; **department of Paediatrics, university of Piemonte Orientale, 
novara, italy; ††department of Paediatrics, Hospital universitario niño 
Jesús; ‡‡department of Paediatrics, Hospital 12 de Octobre, Madrid, Spain; 
§§academic Medical Center, amsterdam, the netherlands; ¶¶Charles uni-
versity in Prague, Faculty of Medicine in Pilsen, department of Paediatrics, 
Prague, Czech republic; ‖‖First department of Paediatrics, Semmelweis 
university, Budapest, Hungary; ***First department of Paediatrics of ath-
ens university, athens, greece; †††department of Paediatrics, Marmara 
university Hospital, istanbul, turkey; and ‡‡‡inserm u853, Victor Segalen 
Bordeaux 2 university, Bordeaux, France.
the authors have no other funding or conflicts of interest to disclose.
address for correspondence: Patrick Bontems, Pediatric gastroenterology-
Hepatology, Queen Fabiola Children’s university Hospital, université libre 
de Bruxelles, 15 av JJ Crocq, 1020 Brussels, Belgium. e-mail: patrick.bon-
tems@huderf.be.
The Pediatric Infectious Disease Journal • Volume 32, Number 12, December 2013 Peptic Ulcer Disease
© 2013 Lippincott Williams & Wilkins www.pidj.com | 1325
ulcers and/or erosions, age, gender, known chronic diseases, indi-
cations for endoscopy, endoscopic findings, H. pylori status, medi-
cations during the last 4 weeks, country of birth of the child and 
mother, family history of ulcer, lifestyle habits including smoking, 
alcohol and narcotic consumptions. Children <1 month and >17 
years were excluded. Parental informed consent and child assent 
were obtained as requested by local ethical policy in the different 
european countries for the collection of clinical information in an 
anonymous form. the ethical committee of Queen Fabiola Chil-
dren’s university Hospital, Brussels, Belgium approved the proto-
col for anonymous data collection and analysis.
H. pylori status was determined according to various diagnos-
tic methods as already defined: histology according to the updated 
Sydney classification, culture, rapid urease test, 13C-urea breath test 
and monoclonal stool antigen. H. pylori infection was confirmed 
when culture or at least 2 other diagnostic tests were positive.21
to limit interindividual interpretation of endoscopic findings 
between observers in the different centers, a clear description and 
definition of ulcers and erosions was adopted by consensus accord-
ing to the minimal standard terminology for digestive endoscopy: 
ulcer was defined as a deep defect in the mucosa with an inflamed 
edge; erosion was defined as a small (<3 mm) superficial defect in 
the mucosa of a white or yellow.22
Data Analysis
the statistical analysis was done using Statistical Package 
for Social Sciences, version 21.0 (SPSS, iBM, armonk, nY). the 
medians and the ranges were calculated for all continuous variables 
as well as repartition for qualitative parameters. Children having 
received antimicrobials, proton pump inhibitors or H
2
-blockers dur-
ing the preceding 4 weeks were excluded for the analysis of risk. the 
distributions of nongaussian continuous variables between 2 sam-
ples were compared using the nonparametric Mann-Whitney U test. 
For qualitative variables, monovariate and multivariate statistical 
analyses were done by logistic regression with adjustment for cent-
ers and age groups. the presence of gastric and/or duodenal ulcers 
or erosions (cases) and the different types of lesions (gastric ulcer, 
duodenal ulcer, gastric and duodenal ulcer, gastric erosions, duode-
nal erosions, gastric and duodenal erosions) were introduced succes-
sively as dependent variables. the covariates were H. pylori infec-
tion, gender, known associated chronic diseases, use of medication, 
lifestyle and familial factors as described in our previous article.1 a 
χ2 for homogeneity between centers was also calculated for each sig-
nificant covariate. a calculation of the size of the population needed 
to test the hypothesis that gastro-duodenal lesions are mainly caused 
by H. pylori was first done using the data of our pilot study and a 
crude estimation of a H. pylori frequency of 15% in controls. using 
these settings, 81 patients and 162 controls were needed for ulcers 
and the same numbers for erosions to obtain a statistically signifi-
cant difference. results were expressed as odds ratio (Or) with their 
95% confidence intervals (95% Ci). Statistical significance was set 
up at the P < 0.05 level, and all P values were 2 tailed.
RESULTS
a total of 732 children (244 cases and 488 controls cross-
matched for age groups) were enrolled, 383 boys and 349 girls, 
with a median age of 11.1 years, range 1 month to 17.8 years and 
interquartile range extending from 6.8 to 14.4 years. Of these 244 
enrolled children with gastric and/or duodenal lesions, 102 were 
included by the Belgian center (and 204 controls), 48 by the Polish 
center (and 96 controls), 23 by the Swedish center (and 46 con-
trols), between 10 and 20 each by the german and the French cent-
ers (and 2 age-matched controls from the same center for each case) 
and <10 each by the Czech, greek, Hungarian, italian, Spanish and 
dutch centers (and 2 age-matched controls from the same center 
for each case). the main indications for upper gi endoscopy were 
(>1 possible): abdominal pain (113/244 cases vs. 196/488 controls, 
nonsignificant [nS]), epigastric tenderness (82/244 vs. 148/488, 
nS), failure to thrive (45/244 vs. 112/488, nS), vomiting (52/244 
vs. 79/488, nS), heartburn (28/244 vs. 82/488, nS), chronic diar-
rhea (23/244 vs. 41/488, nS), halitosis (23/244 vs. 41/488, nS) and 
nausea (18/244 vs. 44/488, nS).
the H. pylori status was determined in 708/732 children: 
by means of gastric biopsies in 707/732 children (232/244 cases 
and 475/488 controls) and by means of 2 concordant noninvasive 
tests in 1 control child. in the remaining 24 children, H. pylori 
status was not determined since biopsies could not be obtained 
due to several contraindications (such as emergency endoscopies 
for foreign body retrieval or hemorrhage, anticoagulant therapy, 
hemodynamically compromised children in intensive care unit) 
and noninvasive tests were not performed. Histologic studies were 
performed in the biopsy samples of all children, whereas culture 
was obtained in 581/707 (82.2%), rapid urease test in 346/707 
(48.9%), 13C-urea breath test in 67/707 (9.5%) and stool antigen in 
49/707 (6.9%). Children having received either antimicrobials (21 
cases and 29 controls), proton pump inhibitors (16 cases and 52 
controls) or H
2
-blockers (5 cases, 17 controls) during the preceding 
4 weeks were excluded for the analysis because these medications 
could have masked the severity of the lesions and could have inter-
fered with H. pylori status determination. the characteristics of the 
remaining 592 children (202 cases and 390 controls) are shown in 
table 1. as shown, in a monovariate model, exposure factors asso-
ciated with an increasing risk of lesions were male gender, H. pylori 
infection, chronic renal diseases, nSaids use and active smoking. 
Conversely, absence of concomitant medication and celiac disease 
were significantly more frequent in controls. in a multivariate anal-
ysis, significant independent factors associated with gastro-duode-
nal lesions were H. pylori infection (Or: 1.911, 95% Ci: 1.221–
2.992, P = 0.005), male gender (Or: 1.788, 95% Ci: 1.220–2.620, 
P = 0.003), chronic renal diseases (Or: 3.842, 95% Ci: 1.148–
12.854, P = 0.029) and active smoking (Or: 4.936, 95% Ci: 1.418–
17.180, P = 0.012). gastro-duodenal ulcers/erosions are more fre-
quent in the older age groups and there is a positive correlation 
between age and H. pylori infection as shown in Figure 1.
Gastric and Duodenal Ulcers
ulcers were observed in 71/202 children (gastric ulcers in 
34, duodenal ulcers in 34 and both gastric and duodenal ulcers in 3). 
exposure factors associated with gastric ulcers or duodenal ulcers 
in a monovariate model are shown in the table 2 and in a multi-
variate model in table 3. Significant independent factors associated 
with gastric ulcers were male gender, chronic neurologic disease, 
chronic renal disease and nSaid use. independent factors associ-
ated with duodenal ulcers were H. pylori infection and steroid use. 
no independent exposure factors could be associated with ulcera-
tions in both the gastric and duodenal mucosa.
Gastric and Duodenal Erosions
erosions alone were observed in 131/202 children (gastric 
erosions in 83, duodenal erosions in 38, gastric and duodenal ero-
sions in 10). exposure factors associated with these lesions in a 
monovariate model are shown in the table 2 and in a multivariate 
model in table 3. the only significant independent factor associ-
ated with gastric erosions was chronic renal disease. independent 
factors associated with duodenal erosions were H. pylori infection, 
active smoking and chronic arthritis. independent exposure factors 
associated with gastric and duodenal erosions were active smoking 
and a previous successful H. pylori eradication.
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Ulcers and Erosions Occurring in Children not 
Exposed to an Identified Associated Factor
in 105/202 children (52.0%) presenting with ulcers and/or 
erosions, the lesions could have been due to 1 of the following fac-
tors: H. pylori infection, inflammatory bowel disease, polyarthritis 
and other rheumatic diseases, chronic renal disease, stress caused by 
admission in an intensive care unit (including oncology and neonatal 
units), use of nSaid, steroid, immunosuppressive agent, chronic neu-
rologic disease or tobacco consumption. in 97/202 patients (48.0%), 
no exposure factor potentially responsible of gastric and/or duodenal 
lesions could be identified. lesions with unexplained etiology were 
more frequent in the stomach than in the duodenum (68/117–58.1% 
vs. 24/72–33.3%, respectively, Or: 2.776, 95% Ci: 1.505–5.120, 
P = 0.002). Simultaneous gastric and duodenal mucosal lesions with 
unexplained etiology were found in 5/13 children (38.5%).
DISCUSSION
H. pylori and chronic use of nSaids were recognized as 
the most common causes of gastro-duodenal ulcers in adults. in 
children, chronic use of nSaids is infrequent and mucosal lesions 
due to H. pylori are thought to need decades to develop after the pri-
mary infection. as a consequence, peptic gastro-duodenal lesions 
are considered as rare in children.
However, in our previous prospective european multicenter 
study, we found that 8.1% of dyspeptic children referred for upper 
gi endoscopy in european centers presented ulcers and/or ero-
sions in the stomach and/or in the duodenum.1–4 these lesions were 
observed mainly around the second decade of life with a high vari-
ability among the different centers. in the present study, we analyzed 
the other exposure factors associated with gastro-duodenal lesions 
in an age-matched case-control prospective multicenter design. Our 
results show that H. pylori infection is independently associated with 
duodenal ulcers and duodenal erosions but not with gastric lesions. 
nSaids use is only independently associated with gastric ulcers and 
only marginally steroids with duodenal ulcers. additionally, male 
gender is independently associated with gastric ulcers and active 
smoking with gastric and with duodenal erosions. Patients with 
chronic renal diseases have a higher risk of gastric ulcers and gastric 
erosions, those with chronic neurologic diseases have a higher risk of 
TABLE 1. Monovariate Analysis of Exposure Factors in Children With Gastro-duodenal Ulcer and/or Erosions 
Compared to Controls After Exclusion of Patients Having Received Antimicrobials, PPIs or H2-blockers During the 
Last 4 Weeks
Cases (n = 202) Controls (n = 390) OR Adjusted* OR 95% CI adjusted* OR P
Median age (range) in years 10.9 (0.1–17.8) 10.9 (0.2–17.8) NS
Male 118 190 1.479 1.489 1.049–2.113 0.026
Migrant 26 (12.9%) 34 (8.7%) 1.551 1.571 0.902–2.734 0.110
  Unknown 1 1
Migrant family 65 (32.3%) 117 (30.1%) 1.111 1.073 0.715–1.612 0.734
  Unknown 1 1
Previous endoscopy 45 (22.3%) 87 (22.3%) 0.998 1.015 0.664–1.551 0.946
Previous H. pylori eradication 11 (5.8%) 8 (2.1%) 2.842 3.125 1.194–8.182 0.002
  Unknown 12 12
H. pylori infection 60 (31.6%) 72 (19.0%) 1.962 2.006 1.329–3.030 0.001
  Unknown 12 12
Family history PUD 59 (30.7%) 110 (28.9%) 1.089 1.092 0.738–1.615 0.660
  Unknown 10 10
Celiac disease 5 (2.5%) 36 (9.2%) 0.250 0.226 0.083–0.615 0.004
Chronic renal diseases 8 (4.0%) 5 (1.3%) 3.175 3.323 1.056–10.456 0.040
No associated chronic disease 107 (53.0%) 196 (50.3%) 1.115 0.893 0.614–1.298 0.552
Allergic diseases (except food allergy) 12 (5.9%) 39 (10.0%) 0.568 0.579 0.290–1.155 0.121
Inflammatory bowel disease 18 (8.9%) 23 (5.9%) 1.561 1.646 0.817–3.313 0.163
Food allergy 16 (7.9%) 21 (5.4%) 1.512 1.586 0.779–3.228 0.204
Chronic neurologic diseases 10 (5.0%) 19 (4.9%) 1.017 1.017 0.455–2.273 0.968
Chronic pulmonary diseases 6 (3.0% 23 (5.9%) 0.488 0.455 0.181–1.148 0.095
Chronic liver diseases 7 (3.5) 15 (3.8%) 0.897 0.929 0.335–2.576 0.887
Diabetes mellitus 7 (3.5%) 9 (2.3%) 1.520 1.579 0.565–4.409 0.383
Chronic ENT diseases 4 (2.0%) 9 (2.3%) 0.855 0.824 0.244–2.779 0.755
Prematurity 3 (1.5%) 5 (1.3%) 1.161 1.106 0.252–4.852 0.894
Congenital heart disease 3 (1.5%) 4 (1.0%) 1.455 1.586 0.338–7.448 0.559
GERD 1 (0.5%) 6 (1.5%) 0.318 0.286 0.033–2.473 0.255
Juvenile polyarthritis 4 (2.0%) 3 (0.8%) 2.606 2.951 0.629–13.837 0.170
Other chronic diseases† 19 (9.4%) 35 (9.0%) 0.884 0.887 0.433–1.818 0.744
No drug consumption 133 (65.8%) 282 (72.3%) 0.738 0.636 0.418–0.968 0.035
NSAIDs 23 (11.4%) 24 (6.2%) 1.959 2.054 1.100–3.836 0.024
Steroids 8 (4.0%) 8 (4.0%) 1.969 1.999 0.724–5.520 0.181
Immunosuppressive agents 4 (2.0%) 12 (3.1%) 0.636 0.634 0.195–2.064 0.449
Occasional alcohol consumption 16 (8.0%) 19 (4.9%) 1.689 1.836 0.892–3.780 0.099
  Unknown 2 2
Active smoking 12 (6.0%) 4 (1.0%) 6.111 6.801 2.097–22.057 0.001
  Unknown 1 1
Bold indicates statistically significant exposure factors in blood.
* Adjusted for centers and age groups.
†Other chronic diseases (in order of frequency): malignancy, eosinophilic esophagitis, neonatal stress, patients in intensive care unit, organ transplantation, hypothyroidism, 
down syndrome and other genetic abnormalities, cystic fibrosis, active tuberculosis, metabolic diseases, chronic pancreatitis and sickle cell disease. More than 1 associated disease 
possible.
PUD, peptic ulcer disease; GERD, gastro-esophageal reflux disease; ENT, ear, nose and throat.
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gastric ulcers, those with chronic juvenile arthritis have a higher risk 
of duodenal erosions. However, excluding H. pylori, the fractions of 
cases attributable to these different risk factors were small. Finally, 
the main finding is the confirmation that ulcers/erosions occur in a 
large proportion of children that were not exposed to identifiable risk 
factor in our population and remain currently unexplained.1
Potential bias could be the under detection of H. pylori 
infection and the underreported use of medications and/or of 
etiological factors. However, the diagnostic tests for H. pylori 
were very reliable. the H. pylori status was mainly based on con-
cordant histology and culture results (559/581 children, 96.2%). 
H. pylori culture was very sensitive in the participating centers 
with a negative predictive value of 96.6%: in only 16 children, 
H. pylori-like microorganisms were identified on histology but 
culture remained negative while H. pylori infection was confirmed 
by another test. the same applies for histology: in 6 other chil-
dren, no H. pylori-like microorganism was identified histologically 
although H. pylori culture was positive and infection confirmed by 
another test (negative predictive value of histology for H. pylori 
detection 98.9%). Since the H. pylori status was not determined in 
24 patients (12 cases and 12 controls), we performed the statistical 
analysis including also the “best case scenario” (we hypothesize 
they are all infected) and the “worst case scenario” (we hypothesize 






TABLE 2. Monovariate Analysis of Exposure Factors in Children With Gastric Ulcer or Duodenal Ulcer or Gastric 
Erosions or Duodenal Erosions or Gastric and Duodenal Erosions Compared to Controls (Logistic Regression Adjusted 
for Center and Age Groups) After Exclusion of Patients Having Received Antimicrobials, PPIs or H2-blockers During the 
Last 4 Weeks
Gastric Ulcer Duodenal Ulcer Gastric Erosions
Duodenal  
Erosions
Gastric and Duodenal  
Erosions
N 34 34 83 38 10
Median age (range) in year 10.1 (0.2–17.7) 12.6 (1.7–17.1) 10.3 (0.1–17.8) 11.7 (0.9–17.2) 10.7 (2.5–16.8)
Male 26 (76%)* 21 (62%) 41 (49%) 21 (55%) 6 (60%)
H. pylori infection 8 (27%) 18 (53%)* 17 (22%) 13 (35%)† 4 (40%)
  Unknown 4 0 7 1 0
No chronic disease 18 (53%) 16 (47%) 48 (58%) 20 (53%) 5 (50%)
Chronic neurologic diseases  5 (15%)* 2 (6%) 3 (4%) 0 0
Chronic renal diseases  3 (9%)* 1 (3%)  4 (5%)† 0 0
Juvenile polyarthritis 0 0 1 (1%)  3 (8%)* 0
Other chronic diseases 3 (9%) 5 (15%) 0 1 (3%) 2 (20%)
No drug consumption 22 (65%) 23 (68%) 60 (72%) 24 (63%)  3 (30%)†
NSAIDs 4 (12%) 5 (15%) 8 (10%) 2 (5%) 2 (20%)
  Ibuprofen 2 2 3 2 1
  5-aminosalicylic acids 0 1 3 0 1
  Acetylsalicylic acid 1 2 0 0 0
  Others 1 0 2 0 0
Steroids 2 (6%)  3 (9%)† 1 (1%) 1 (3%) 0
Occasional alcohol consumption 1 (3%) 1 (3%) 7 (9%)  6 (16%)* 1 (10%)
  Unknown 1 0 1 0 0
Active smoking 1 (3%) 2 (6%)  4 (5%)†  4 (11%)*  1 (10%)†
  Unknown 1 0 0 0 0
Bold indicates statistically significant exposure factors.
* P < 0.01.
† P < 0.05.
See Table 1 for data of the controls and other chronic diseases.
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they are all negative for H. pylori) but this did not change the main 
messages nor the statistical significances.
the study was prospective and a precise questionnaire was 
used to record the anamnestic data. the questionnaire was carefully 
reviewed with the children and the families by the investigators. 
We accept however that intake of some medications could have not 
been reported: for example tobacco, alcohol and narcotic consump-
tion seems underreported taking into account the current lifestyle 
of adolescents. Perhaps children may have avoided admitting these 
consumptions in presence of their parents. However, it is unlikely 
that such underreported factors could affect half of the children’s 
population. the same could apply for underreported and nondiag-
nosed chronic diseases such as iBd.
Other monocentric studies recently published show that the 
incidence of ulcers in children is not negligible, at least in some 
countries, that these lesions are not only due to H. pylori or gas-
trotoxic medications and that there is a higher risk for men. in 
israel, gastro-duodenal ulcers were detected in 51/751 (6.8%, 
M/F = 0.9) and erosions in 118/751 (15.7%) children referred for 
upper gi endoscopy. the proportion of lesions unrelated to drugs 
or H. pylori infection was only 29% but in this region the preva-
lence of H. pylori infection is higher than in our population.17 in 
taiwan, 67/1234 (5.4%, M/F = 2.5) children presented with gastric 
or duodenal ulcers, 36% unrelated to drugs or H. pylori infection.20 
in Hong Kong, 51/619 (6.9%, M/F = 2.6) children presented with 
gastric or duodenal ulcers, 46% unrelated to drugs or H. pylori 
infection.18 nevertheless, a much lower frequency (around 2%) of 
ulcers was reported in some other countries.12,14,16 the male pre-
dominance, found in some studies, may be due to endocrinologic 
factors.23,24 the apparent different prevalence of gastro-duodenal 
lesions between these different studies may be biased by the fact 
that the lifestyles are not comparable, unequal availability of endos-
copy facilities, referral policy to third level hospitals with endos-
copy facilities, total number of endoscopy per year, proportion of 
older children in each center (lesions more frequent in older ones), 
PPi’s prescription policy without endoscopy or H. pylori frequency 
in the local population. Similar bias may explain discrepancies 
between the different centers participating in the study.
Older studies also described H. pylori-negative and nSaid-
negative ulcers/erosions as well as a stronger association of 
H. pylori infection with duodenal lesions compared with gastric 
ones. in the first meta-analysis published by Macarthur in 1995,9 
92% of children with duodenal ulcer were infected but only 25% 
of those with gastric ulcer, while the prevalence of infection in 
controls with nonulcer dyspepsia was 22%. in more recent pedi-
atric publications and in our study, the prevalence of H. pylori in 
duodenal ulcer is lower. as suggested in adults, it is possible that 
the declining prevalence of H. pylori unmasks patients with peptic 
ulcer disease unrelated to H. pylori.25,26
in contrast to the present study, some authors did not include 
erosions in their analysis. Since the causes of both lesions are quite 
similar, we consider that erosions could be an early stage of gastro-
duodenal damage whose natural evolution can be healing or pro-
gression to frank ulcerations.
in previously published articles, treatment with PPis appears 
to be effective and recurrence was low even in case of idiopathic 
lesions but a prospective study must still confirm these data.
We conclude that H. pylori infection is an exposure factor 
associated with duodenal ulcers or erosions, but not with gastric 
lesions in children. Male gender, nSaids, steroids and active 
smoking or chronic renal diseases, juvenile arthritis as well as 
chronic neurologic diseases are independent exposure factors asso-
ciated with gastro-duodenal ulcers/erosions in children. However, 
a high proportion of children with so-called idiopathic ulcers/ero-
sions have no identified associated risk factor. Further studies are 
needed to find a causal etiology in these patients such as, perhaps, 
another exogenous infectious agent or a gastric dysbiosis.
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